Common use of Field Force Monitoring and Review Efforts Clause in Contracts

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 days after the Effective Date, GSK shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (3) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 Within 90 days after the Effective Date, GSK Indivior shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (3) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within ‌ Within 120 days after the Effective Date, GSK Insys shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential offpromotion of products for non-label promotional activities approved uses or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (3) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within Within 120 days after the Effective Date, GSK Merit shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; personnel and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 Within 90 days after the Effective Date, GSK SUN shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (3) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within Within 120 days after the Effective Date, GSK Aegerion shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s (or contracted sales personnel’s) interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label improper promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).; and (3) if applicable, a Speaker Monitoring Program

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 Within 90 days after the Effective Date, GSK RMS shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; personnel and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within Within 120 days after the Effective Date, GSK Endo shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s representatives’ interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s representatives’ interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnelrepresentatives; and (3) the monitoring and review of other records relating to sales personnel’s representatives’ interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within ​ Within 120 days after the Effective Date, GSK Merit shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; personnel and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).. ​ ​ ​ ​ ​ ​

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within ‌ Within 120 days after the Effective Date, GSK USWM shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; and (3) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 days after the Effective Date, GSK BIPI shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s representatives’ interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s representatives’ interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnelrepresentatives; and (3) the monitoring and review of other records relating to sales personnel’s representatives’ interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 ‌ Within 90 days after the Effective Date, GSK RMS shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; personnel and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 Within 90 days after the Effective Date, GSK Biotronik shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s interactions with HCPs and HCIs and to identify potential off-label promotional improper promotional‌ activities or other improper conduct. As described in more detail below, the FFMP shall include: : (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnel; personnel and (32) the monitoring and review of other records relating to sales personnel’s interactions with HCPs and HCIs (Records Reviews).

Field Force Monitoring and Review Efforts. To the extent not already accomplished, within 120 days after the Effective Date, GSK Novartis shall establish a comprehensive Field Force Monitoring Program (FFMP) to evaluate and monitor its sales personnel’s representatives’ interactions with HCPs and HCIs. The FFMP shall be a formalized process designed to directly and indirectly observe the appropriateness of sales personnel’s representatives’ interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct. As described in more detail below, the FFMP shall include: (1) a Speaker Monitoring Program; (2) direct field observations (Observations) of sales personnelrepresentatives; and (3) the monitoring and review of other records relating to sales personnel’s representatives’ interactions with HCPs and HCIs (Records Reviews).